BDBM50091845 (S)-4-[Bis-(4-benzyloxy-benzyl)-amino]-4-{2-[2-(2-{(R)-2-[bis-(4-benzyloxy-benzyl)-amino]-4-carboxy-butyrylamino}-ethoxy)-ethoxy]-ethylcarbamoyl}-butyric acid::CHEMBL387062

SMILES OC(=O)CC[C@@H](N(Cc1ccc(OCc2ccccc2)cc1)Cc1ccc(OCc2ccccc2)cc1)C(=O)NCCOCCOCCNC(=O)[C@H](CCC(O)=O)N(Cc1ccc(OCc2ccccc2)cc1)Cc1ccc(OCc2ccccc2)cc1

InChI Key InChIKey=QYGVWIKNPVFLJG-NBHUNHBSSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50091845   

TargetErythropoietin receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50091845((S)-4-[Bis-(4-benzyloxy-benzyl)-amino]-4-{2-[2-(2-...)
Affinity DataIC50:  7.50E+4nMAssay Description:Compound was evaluated for inhibition of [125I]-EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed